Date:7/30/2009

814 236,728 242,377 Operating expenses: Cost of product sales (excluding acquisition- related intangibles amortization) 38,280 32,510 71,594 65,146 Acquisition-related intangibles amortization 1,114 - 1,114 - Research and development 26,069 29,368 51,067 52,434 Marketing and sales 14,015 11,453 25,070 23,361 General and administrative 17,823 13,671 31,670 25,608 ------ ------ ------ ------ Total operating expenses 97,301 87,002 180,515 166,549 ------ ------ ------- ------- Income from operations 23,244 32,812 56,213 75,828 Other income/(expense): Interest income 10,122 3,900 15,004 8,107 Interest expense (726) (2) (877) (2) Other income/(expense) (895) (191) (1,037) 1,282 ---- ---- ------ ----- Total other income, net 8,501 3,707 13,090 9,387 ----- ----- ------ ----- Income before income tax 31,745 36,519 69,303 85,215 Income tax expense 11,930 11,728 23,741 28,479 ------ ------ ------ ------ Net income $19,815 $24,791 $45,562 $56,736 ======= ======= ======= ======= Net income per share: Basic $0.39 $0.46 $0.88 $1.05 ===== ===== ===== ===== Diluted $0.38 $0.45 $0.87 $1.03 ===== ===== ===== ===== Weighted av
'/>"/>

SOURCE Gen-Probe Incorporated Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Reports Financial Results for First Quarter 2009
3. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
4. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
5. Tepnel Shareholders Approve Acquisition by Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
7. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
8. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
9. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
10. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference